Novel haptens and monoclonal antibodies with subnanomolar affinity for a classical analytical target, ochratoxin A
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Novel haptens and monoclonal antibodies with subnanomolar affinity for a classical analytical target, ochratoxin A ; volume:8 ; number:1 ; day:27 ; month:6 ; year:2018 ; pages:1-9 ; date:12.2018
Scientific reports ; 8, Heft 1 (27.6.2018), 1-9, 12.2018
- Klassifikation
-
Biowissenschaften, Biologie
- Urheber
-
López-Puertollano, Daniel
- Beteiligte Personen und Organisationen
-
Mercader, Josep V.
Agulló, Consuelo
Abad-Somovilla, Antonio
Abad-Fuentes, Antonio
SpringerLink (Online service)
- DOI
-
10.1038/s41598-018-28138-x
- URN
-
urn:nbn:de:101:1-2018083123440492246562
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:24 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- López-Puertollano, Daniel
- Mercader, Josep V.
- Agulló, Consuelo
- Abad-Somovilla, Antonio
- Abad-Fuentes, Antonio
- SpringerLink (Online service)
Ähnliche Objekte (12)
Production and characterization of monoclonal antibodies against ochratoxin B
Monoclonal antibodies
High-affinity monoclonal antibodies against the porcine epidemic diarrhea virus S1 protein
Monoclonal antibodies in transplantation
Glycoengineering of Monoclonal Antibodies
Arthrogenicity of type II collagen monoclonal antibodies associated with complement activation and antigen affinity
Generation and characterization of high affinity human monoclonal antibodies that neutralize staphylococcal enterotoxin B
Differences in affinity of monoclonal and naturally acquired polyclonal antibodies against Plasmodium falciparum merozoite antigens
Advancing SARS‐CoV‐2 Variant Detection with High Affinity Monoclonal Antibodies and Plasmonic Nanostructure
Development and application of classical swine fever virus monoclonal antibodies derived from single B cells
Clinical relevance of new monoclonal antibodies
Establishment of anti-mesothelioma monoclonal antibodies
Production and characterization of monoclonal antibodies against ochratoxin B
Monoclonal antibodies
High-affinity monoclonal antibodies against the porcine epidemic diarrhea virus S1 protein
Monoclonal antibodies in transplantation
Glycoengineering of Monoclonal Antibodies
Arthrogenicity of type II collagen monoclonal antibodies associated with complement activation and antigen affinity
Generation and characterization of high affinity human monoclonal antibodies that neutralize staphylococcal enterotoxin B
Differences in affinity of monoclonal and naturally acquired polyclonal antibodies against Plasmodium falciparum merozoite antigens
Advancing SARS‐CoV‐2 Variant Detection with High Affinity Monoclonal Antibodies and Plasmonic Nanostructure
Development and application of classical swine fever virus monoclonal antibodies derived from single B cells
Clinical relevance of new monoclonal antibodies
Establishment of anti-mesothelioma monoclonal antibodies
Production and characterization of monoclonal antibodies against ochratoxin B
Monoclonal antibodies
High-affinity monoclonal antibodies against the porcine epidemic diarrhea virus S1 protein
Monoclonal antibodies in transplantation
Glycoengineering of Monoclonal Antibodies
Arthrogenicity of type II collagen monoclonal antibodies associated with complement activation and antigen affinity
Generation and characterization of high affinity human monoclonal antibodies that neutralize staphylococcal enterotoxin B
Differences in affinity of monoclonal and naturally acquired polyclonal antibodies against Plasmodium falciparum merozoite antigens
Advancing SARS‐CoV‐2 Variant Detection with High Affinity Monoclonal Antibodies and Plasmonic Nanostructure
Development and application of classical swine fever virus monoclonal antibodies derived from single B cells
Clinical relevance of new monoclonal antibodies